MCID: LYM022
MIFTS: 55

Lymphangioma malady

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Lymphangioma

About this section

Aliases & Descriptions for Lymphangioma:

Name: Lymphangioma 11 13 48 37 66
Congenital Lymphangioma 11
 
Benign Lymphangioma 11
Lymphangiomas 25

Classifications:



External Ids:

Disease Ontology11 DOID:1475
ICD1028 D18.1
ICD9CM30 228.1
MeSH37 D008202
NCIt43 C8965

Summaries for Lymphangioma

About this section
Wikipedia:69 Lymphangiomas are malformations of the lymphatic system characterized by lesions that are thin-walled... more...

MalaCards based summary: Lymphangioma, also known as congenital lymphangioma, is related to hemangioma, capillary infantile and breast cancer, and has symptoms including pain of lymph node An important gene associated with Lymphangioma is FLT4 (Fms Related Tyrosine Kinase 4), and among its related pathways are Angiogenesis (CST) and Hypertrophy Model. Affiliated tissues include pancreas, lymph node and tongue, and related mouse phenotypes are liver/biliary system and integument.

Related Diseases for Lymphangioma

About this section

Diseases related to Lymphangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 221)
idRelated DiseaseScoreTop Affiliating Genes
1hemangioma, capillary infantile30.5FLT4, KDR
2breast cancer26.9EGFR, FLT4, KDR, PIK3CA, VEGFA, VEGFC
3cystic lymphangioma12.3
4capillary lymphangioma12.1
5abdominal cystic lymphangioma12.1
6cavernous lymphangioma12.1
7colonic lymphangioma12.1
8orbital lymphangioma12.0
9microcystic lymphatic malformation12.0
10primary laryngeal lymphangioma12.0
11lymphatic malformations11.7
12mixed cystic lymphatic malformation11.2
13diffuse lymphatic malformation11.1
14sebaceous adenocarcinoma10.6FLT4, IFNA2
15congenital cystic eye multiple ocular and intracranial anomalies10.6FLT4, KDR
16hemangioma10.6
17orofaciodigital syndrome vii10.6FLT4, VEGFC
18nuchal bleb, familial10.5
19adult cerebellar neoplasm10.4FLT4, HBA1
20cobb syndrome10.4
21vascular malformation10.4
22orbital varix10.4EGFR, FLT4
23hyperlucent lung10.4FLT4, HBA1
24tooth erosion10.4HBA1, KDR
25mediastinitis10.3
26gingival overgrowth10.3IFNG, PIK3CA
27cavernous hemangioma10.3
28kaposiform hemangioendothelioma10.3
29retiform hemangioendothelioma10.3
30pancreatitis10.3
31tamoxifen-related endometrial lesion10.2EGFR, PIK3CA
32cervicitis10.2
33frontotemporal dementia and/or amyotrophic lateral sclerosis 410.2KDR, PIK3CA, VEGFC
34malignant giant cell tumor of soft parts10.2EGFR, KDR
35eversion of lacrimal punctum10.2EGFR, PIK3CA
36tic disorder10.2EGFR, PIK3CA
37trachea adenoid cystic carcinoma10.2EGFR, PIK3CA
38breast papillary carcinoma10.2EGFR, PIK3CA
39mediastinal neurilemmoma10.2PIK3CA, VEGFC
40hydromyelia10.2FLT4, VEGFA
41esophagus leiomyosarcoma10.2HBA1, IFNA2
42ovarian small cell carcinoma10.1EGFR, PIK3CA
43hepatitis10.1
44lymphangiomatosis10.1
45bladder urachal carcinoma10.1KDR, VEGFA
46endotheliitis10.1
47collagen disease10.1IFNA2, IFNG
48arthrogryposis, ectodermal dysplasia, cleft lip/palate, and developmental delay10.0KDR, VEGFA
49adenosquamous carcinoma10.0EGFR, PIK3CA
50iliac vein thrombophlebitis10.0KDR, VEGFA

Comorbidity relations with Lymphangioma via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Lymphangioma:



Diseases related to lymphangioma

Symptoms for Lymphangioma

About this section

UMLS symptoms related to Lymphangioma:


pain of lymph node

Drugs & Therapeutics for Lymphangioma

About this section

Drugs for Lymphangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Sildenafil citratePhase 1, Phase 2315171599-83-0
2
Citric AcidPhase 1, Phase 2106377-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
3
OctreotidePhase 220683150-76-9383414, 6400441
Synonyms:
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
79517-01-4 (acetate salt)
83150-76-9
AC1L1GVU
AC1L8LCD
AC1L9M4X
C07306
C5H12O2.C4H10
CHEBI:427278
CHEBI:611465
CHEMBL1680
CID383414
CID448601
CID54374
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide
D00442
DRG-0115
HMS2090C09
HS-2020
 
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*
L000453
LS-177735
LS-187135
Longastatin
NCGC00181796-01
NCI60_025753
Octreotida
Octreotida [Spanish]
Octreotide
Octreotide (USAN/INN)
Octreotide Acetate Salt
Octreotide [USAN:INN:BAN]
Octreotide-LAR
Octreotidum
Octreotidum [Latin]
Octrotide
SAN 201-995
SM 201-995
SMS 201-995
SMS-201-995
Sandostatine
Sandoz 201-995
UNII-RWM8CCW8GP
nchembio.184-comp3
zacycloicosane-4-carboxamide acetate
4
sirolimusPhase 2186353123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
5
MiconazolePhase 2357322916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
6
EverolimusPhase 21863159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
7CitrateNutraceuticalPhase 1, Phase 21063
8
MarimastatPhase 14154039-60-8119031
Synonyms:
(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide
(2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoxy)propyl)carboyl)-2-hydroxy-5-methylhexanohydroxamic acid
(2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl)carbamoyl)-2-hydroxy-5-methylhexanohydroxamic acid
(2S,3R)-N(4)-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N(1),2-dihydroxy-3-(2-methylpropyl)butanediamide
15039-60-8
154039-60-8
AC1L3O2N
BB 2516
BB-2516
C100342
 
C15H29N3O5
CHEBI:50662
CHEMBL279785
CID119031
D03795
DB00786
LS-45634
Marimastat
Marimastat (USAN/INN)
Marimastat [USAN]
UNII-D5EQV23TDS
9
seleniumPhase 11717782-49-2
Synonyms:
Selanediide
Selenide
 
Selenide(2-)
Selenium
Selenium ion (Se2+)
10
PancrelipasePhase 091753608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
11pancreatinPhase 0917

Interventional clinical trials:

(show all 16)
idNameStatusNCT IDPhase
1Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic MalformationsCompletedNCT00010452Phase 2, Phase 3
2A Study to Evaluate Sildenafil for the Treatment of Lymphatic MalformationsCompletedNCT01290484Phase 1, Phase 2
3Sildenafil for the Treatment of Lymphatic MalformationsRecruitingNCT02335242Phase 2
4Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage SurgeryRecruitingNCT02437825Phase 2
5Safety and Efficacy Study of Sirolimus in Complicated Vascular AnomaliesActive, not recruitingNCT00975819Phase 2
6Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.CompletedNCT00261391Phase 1
7Selenium in the Treatment of Complicated Lymphatic MalformationsTerminatedNCT01212965Phase 1
8Diagnosis of Hemangiomas and Vascular MalformationsCompletedNCT00577213
9Lymphatic Anomalies RegistryRecruitingNCT02399527
10Registry for Vascular Anomalies Associated With CoagulopathyRecruitingNCT00576888
11AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)RecruitingNCT02250456
12Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic LesionsRecruitingNCT02494388Phase 0
13Characterization of the Pathogenesis of Primary and Secondary Lymphatic DisordersRecruitingNCT02156115
14Airway Vascular LesionsActive, not recruitingNCT00866827
15Imaging of Lymphatic AnomaliesEnrolling by invitationNCT02744027
16Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic DisordersEnrolling by invitationNCT00833599

Search NIH Clinical Center for Lymphangioma


Cochrane evidence based reviews: lymphangioma

Genetic Tests for Lymphangioma

About this section

Genetic tests related to Lymphangioma:

id Genetic test Affiliating Genes
1 Lymphangioma25

Anatomical Context for Lymphangioma

About this section

MalaCards organs/tissues related to Lymphangioma:

34
Pancreas, Lymph node, Tongue, Colon, Spleen, Breast, Endothelial

Animal Models for Lymphangioma or affiliated genes

About this section

MGI Mouse Phenotypes related to Lymphangioma:

39 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.4EGFR, FLT4, IFNG, KDR, VEGFA
2MP:00107718.0EGFR, FLT4, IFNG, KDR, PIK3CA, VEGFA
3MP:00053817.9EGFR, FLT4, IFNG, SERPINF1, VEGFA
4MP:00053697.8EGFR, FLT4, IFNG, KDR, PIK3CA, VEGFA
5MP:00053807.8EGFR, FLT4, IFNG, KDR, PIK3CA, VEGFA
6MP:00030127.8EGFR, FLT4, IFNG, KDR, PIK3CA, VEGFA
7MP:00053897.6EGFR, FLT4, IFNG, PIK3CA, SERPINF1, VEGFA
8MP:00053907.3EGFR, IFNG, KDR, PIK3CA, SERPINF1, VEGFA
9MP:00053917.0EGFR, IFNG, KDR, PIK3CA, SERPINF1, VEGFA
10MP:00053877.0EGFR, FLT4, IFNG, KDR, PIK3CA, SERPINF1
11MP:00053856.6EGFR, FLT4, IFNG, KDR, PIK3CA, SERPINF1

Publications for Lymphangioma

About this section

Articles related to Lymphangioma:

(show top 50)    (show all 955)
idTitleAuthorsYear
1
Torsion of the greater omentum secondary to omental lymphangioma in a child: a case report. (25774241)
2015
2
Coexisting pancreatic mucinous cyst adenoma and adrenal lymphangioma. (25224209)
2014
3
Unusual sites of cystic lymphangioma in children. (25282458)
2014
4
Sildenafil for pediatric orbital lymphangioma. (23828510)
2013
5
Splenic artery rupture during pregnancy concealed by a pancreatic lymphangioma: a rare co-occurrence. (23088804)
2013
6
Adrenal lymphangioma mimicking renal cyst: a case report and review of the literature. (24303224)
2013
7
Cystic fibrosis and retroperitoneal cystic lymphangioma: a novel match. (22273284)
2012
8
Cavernous lymphangioma of the lower lip--a rare case report. (23304957)
2012
9
Lymphangioma: Is intralesional bleomycin sclerotherapy effective? (22279495)
2011
10
A case of laparoscopic excision of a huge retroperitoneal cystic lymphangioma. (22606623)
2011
11
Cystic retroperitoneal lymphangioma. (20557520)
2010
12
Lymphangioma circumscriptum. (21048263)
2010
13
Isolation and characterization of lymphatic endothelial cells from human glossal lymphangioma. (19956870)
2010
14
Infected giant lymphangioma circumscriptum treated with a combination therapy. (20599349)
2010
15
Solitary hepatic lymphangioma in a 22-day-old infant. (19635291)
2009
16
Vulvar lymphangioma circumscriptum. (19682682)
2009
17
Giant lymphangioma of the tongue. (19165040)
2009
18
Haemorrhage in a scrotal lymphangioma in a child: a rarity. (19661642)
2009
19
Cystic lymphangioma of the gallbladder: report of a case. (18085372)
2008
20
Lingual cystic lymphangioma in an elderly patient. (19052498)
2008
21
Lymphangioma circumscriptum. (18627763)
2008
22
Dabska tumor arising in lymphangioma circumscriptum. (18095998)
2008
23
Treatment of lymphangioma in children: our experience of 128 cases. (17270554)
2007
24
Persistent fetal vasculature associated with orbital lymphangioma. (17572349)
2007
25
Treatment of lymphangioma circumscriptum with the intense pulsed light system. (17973881)
2007
26
Scrotal lymphangioma in an adult. (17905123)
2007
27
Cavernous mesenteric lymphangioma (2006: 4b). (16770656)
2006
28
What is your diagnosis? Lymphangioma circumscriptum (benign lymphangiectasia). (16422464)
2005
29
Mesenteric cystic lymphangioma causing intestinal occlusion in an adult patient. (14722994)
2003
30
Giant cystic lymphangioma of the stomach. (11841086)
2001
31
Immunomodulatory treatment with low-dose interferon-alpha and oral retinoic acid in lymphangioma-like Kaposi's sarcoma. (10769722)
2000
32
Protein-loss into retroperitoneal lymphangioma: demonstration by lymphoscintigraphy and blood-pool scintigraphy with Tc-99m-human serum albumin. (10830532)
2000
33
Abdominal cystic lymphangioma in a woman at 14 weeks' gestation: case report. (11055491)
2000
34
Management of orbital lymphangioma using intralesional injection of OK-432. (10837387)
2000
35
Sotradecol (sodium tetradecyl sulfate) injection of orbital lymphangioma. (10588254)
1999
36
Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. (9446823)
1998
37
Mediastinal cystic lymphangioma: report of two cases. (9323827)
1997
38
Progressive fetal axillary cystic lymphangioma with coexistent naevus flammeus. (9039304)
1997
39
Radiology/pathology conference: mesenteric cystic lymphangioma. (8692443)
1996
40
Cystic lymphangioma of the transverse colon: report of a case and review of the literature. (8832861)
1996
41
Laparoscopic resection of a retroperitoneal cystic lymphangioma. (7878511)
1994
42
Renal peripelvic lymphatic cysts (lymphangiomas) associated with generalized lymphangiomatosis. (1290204)
1992
43
Case report: MRI and CT comparison of an orbital cavernous lymphangioma. (1753396)
1991
44
Cystic lymphangioma of the kidney: a rare cause of multiloculated renal masses. (1999216)
1991
45
Abdominal cystic lymphangioma. A case report and a review of the literature. (2180901)
1990
46
Torsion of cavernous lymphangioma: an unusual cause of acute scrotum. (2810511)
1989
47
Sonographic appearance of an abdominal cystic lymphangioma. (6699930)
1984
48
Tumor conference No. 29. An orbital lymphangioma. (7381109)
1980
49
Solitary cystic lymphangioma of the retroperitoneum. (904040)
1977
50
Cavernous lymphangioma in a 20-day-old child. (1150317)
1975

Variations for Lymphangioma

About this section

Expression for genes affiliated with Lymphangioma

About this section
Search GEO for disease gene expression data for Lymphangioma.

Pathways for genes affiliated with Lymphangioma

About this section

Pathways related to Lymphangioma according to GeneCards Suite gene sharing:

(show all 44)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.5FLT4, KDR, VEGFC
29.5IFNG, VEGFA
39.4IFNG, PIK3CA
49.4FLT4, PIK3CA, VEGFC
5
Show member pathways
9.4FLT4, KDR, PIK3CA
69.3HBA1, IFNG
79.3PIK3CA, VEGFA, VEGFC
89.3KDR, PIK3CA, VEGFA
99.3KDR, PIK3CA, VEGFA
10
Show member pathways
9.3KDR, PIK3CA, VEGFA
119.2EGFR, PIK3CA
129.2EGFR, PIK3CA
139.2EGFR, PIK3CA
149.2EGFR, PIK3CA
159.2EGFR, PIK3CA
16
Show member pathways
9.1FLT4, KDR, VEGFA, VEGFC
17
Show member pathways
9.1FLT4, KDR, VEGFA, VEGFC
18
Show member pathways
9.0EGFR, FLT4, KDR
19
Show member pathways
9.0IFNA2, IFNG, PIK3CA
20
Show member pathways
8.8EGFR, PIK3CA, VEGFA
218.8EGFR, PIK3CA, VEGFA
228.8EGFR, IFNA2, PIK3CA
23
Show member pathways
8.7EGFR, FLT4, KDR, VEGFC
248.7EGFR, FLT4, KDR, VEGFC
25
Show member pathways
8.7FLT4, KDR, PIK3CA, VEGFA, VEGFC
26
Show member pathways
8.7FLT4, KDR, PIK3CA, VEGFA, VEGFC
278.7EGFR, IFNG, VEGFA
288.6EGFR, FLT4, KDR, VEGFA
298.6EGFR, IFNA2, IFNG
30
Show member pathways
8.6EGFR, FLT4, KDR, PIK3CA
318.5EGFR, PIK3CA, VEGFA, VEGFC
32
Show member pathways
8.5EGFR, KDR, PIK3CA, VEGFA
338.5EGFR, KDR, PIK3CA, VEGFA
348.5EGFR, KDR, PIK3CA, VEGFA
35
Show member pathways
8.3EGFR, FLT4, KDR, VEGFA, VEGFC
36
Show member pathways
8.3EGFR, FLT4, KDR, VEGFA, VEGFC
378.3EGFR, FLT4, KDR, VEGFA, VEGFC
388.2EGFR, IFNG, PIK3CA, VEGFA
39
Show member pathways
7.9EGFR, FLT4, KDR, PIK3CA, VEGFA, VEGFC
40
Show member pathways
7.9EGFR, FLT4, KDR, PIK3CA, VEGFA, VEGFC
41
Show member pathways
7.6EGFR, FLT4, IFNG, KDR, PIK3CA, VEGFC
427.4EGFR, FLT4, IFNA2, KDR, PIK3CA, VEGFA
43
Show member pathways
7.3EGFR, FLT4, IFNA2, IFNG, KDR, VEGFA
44
Show member pathways
6.8EGFR, FLT4, IFNA2, IFNG, KDR, SERPINF1

GO Terms for genes affiliated with Lymphangioma

About this section

Cellular components related to Lymphangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00056157.4EGFR, IFNA2, IFNG, SERPINF1, VEGFA, VEGFC
2extracellular regionGO:00055766.8FLT4, HBA1, IFNA2, IFNG, KDR, SERPINF1

Biological processes related to Lymphangioma according to GeneCards Suite gene sharing:

(show all 30)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of blood vessel endothelial cell migrationGO:004353610.4VEGFA, VEGFC
2positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathwayGO:003803310.4KDR, VEGFA
3cell migration involved in sprouting angiogenesisGO:000204210.4KDR, VEGFA
4positive regulation of protein kinase C signalingGO:009003710.4FLT4, VEGFA
5positive regulation of protein autophosphorylationGO:003195410.4VEGFA, VEGFC
6positive regulation of positive chemotaxisGO:005092710.4KDR, VEGFA
7positive regulation of focal adhesion assemblyGO:005189410.3KDR, VEGFA
8positive chemotaxisGO:005091810.3VEGFA, VEGFC
9induction of positive chemotaxisGO:005093010.3VEGFA, VEGFC
10vasculature developmentGO:000194410.2FLT4, PIK3CA
11positive regulation of peptidyl-serine phosphorylation of STAT proteinGO:003314110.2IFNA2, IFNG
12positive regulation of endothelial cell migrationGO:001059510.1FLT4, KDR, VEGFA
13positive regulation of endothelial cell proliferationGO:000193810.0FLT4, KDR, VEGFA
14positive regulation of angiogenesisGO:00457669.9KDR, VEGFA, VEGFC
15cellular response to vascular endothelial growth factor stimulusGO:00359249.8FLT4, KDR, VEGFA
16ovulation cycleGO:00426989.7EGFR, SERPINF1
17positive regulation of neuroblast proliferationGO:00020529.7VEGFA, VEGFC
18protein autophosphorylationGO:00467779.4EGFR, FLT4, KDR
19peptidyl-tyrosine phosphorylationGO:00181089.4EGFR, FLT4, KDR
20cellular response to dexamethasone stimulusGO:00715499.3EGFR, SERPINF1
21angiogenesisGO:00015259.3KDR, PIK3CA, VEGFA, VEGFC
22positive regulation of phosphorylationGO:00423279.3EGFR, IFNA2
23negative regulation of gene expressionGO:00106299.3IFNA2, IFNG, SERPINF1
24positive regulation of epithelial cell proliferationGO:00506799.2EGFR, VEGFA, VEGFC
25positive regulation of protein phosphorylationGO:00019349.1EGFR, FLT4, KDR, VEGFA
26positive regulation of cell migrationGO:00303359.1EGFR, KDR, VEGFA
27negative regulation of apoptotic processGO:00430668.7EGFR, FLT4, KDR, VEGFA
28positive regulation of ERK1 and ERK2 cascadeGO:00703748.7EGFR, FLT4, KDR
29vascular endothelial growth factor receptor signaling pathwayGO:00480108.7FLT4, KDR, PIK3CA, VEGFA, VEGFC
30positive regulation of cell proliferationGO:00082847.7EGFR, FLT4, IFNG, KDR, VEGFA, VEGFC

Molecular functions related to Lymphangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1vascular endothelial growth factor-activated receptor activityGO:000502110.4FLT4, KDR
2growth factor bindingGO:001983810.3FLT4, KDR
3chemoattractant activityGO:00420569.8VEGFA, VEGFC
4receptor signaling protein tyrosine kinase activityGO:00047169.8EGFR, KDR
5transmembrane receptor protein tyrosine kinase activityGO:00047149.0EGFR, FLT4, KDR
6cytokine activityGO:00051259.0IFNA2, IFNG, VEGFA

Sources for Lymphangioma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet